<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04986215</url>
  </required_header>
  <id_info>
    <org_study_id>2021-PC-Maker(V1.1）</org_study_id>
    <nct_id>NCT04986215</nct_id>
  </id_info>
  <brief_title>Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy</brief_title>
  <official_title>Research on the Value of Genomics Research Based on Ultrasound Endoscopic Biopsy in the Differential Diagnosis and Prognostic Evaluation of Pancreatic Occupancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To clarify the value of genomic testing in the clinical diagnosis or prognosis of pancreatic&#xD;
      space occupation, provide a basis for the selection of clinical diagnosis methods for&#xD;
      pancreatic space occupation, optimize clinical management strategies, and improve the&#xD;
      prognosis of patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differential microRNA detected by sequencing</measure>
    <time_frame>June 2023</time_frame>
    <description>The diagnosis of microRNA in pancreatic space occupying</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differential mRNA detected by sequencing</measure>
    <time_frame>June 2023</time_frame>
    <description>The diagnosis of mRNA in pancreatic space occupying</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differential lncRNA detected by sequencing</measure>
    <time_frame>June 2023</time_frame>
    <description>The diagnosis of lncRNA in pancreatic space occupying</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pancreatic Space Occupying</condition>
  <arm_group>
    <arm_group_label>Benign pancreatic space occupying group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Malignant pancreatic space occupying group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Occupying lesions of the pancreas, specifically including benign diseases and malignant&#xD;
        diseases, mainly pancreatic cancer has a very high incidence. Elderly patients, especially&#xD;
        those who drink alcohol all year round, have a lot of occurrences, and many patients are&#xD;
        already in the middle or advanced stage when they are diagnosed.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18-85, no gender limit&#xD;
&#xD;
          2. Imaging examinations suggest that the clear pancreas has clear space-occupying lesions&#xD;
&#xD;
          3. Admitted to our department, ready to undergo endoscopic ultrasound biopsy to confirm&#xD;
             the diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. There are contraindications for endoscopic ultrasound biopsy&#xD;
&#xD;
          2. Failed to join the group or refused follow-up due to various reasons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiangyu Kong, associate professor</last_name>
    <phone>13564644397</phone>
    <email>xiangyukong185@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangyu Kong, Associate Professor</last_name>
      <phone>13564644397</phone>
      <email>xiangyukong185@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/30207593/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/21620466/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/25207767/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/27956793/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/26185370/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/20427392/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/15278063/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/29189329/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/23300138/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/30926654/</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32376411/</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313.</citation>
    <PMID>30207593</PMID>
  </reference>
  <reference>
    <citation>Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011 Aug 13;378(9791):607-20. doi: 10.1016/S0140-6736(10)62307-0. Epub 2011 May 26. Review.</citation>
    <PMID>21620466</PMID>
  </reference>
  <reference>
    <citation>Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014 Sep 11;371(11):1039-49. doi: 10.1056/NEJMra1404198. Review.</citation>
    <PMID>25207767</PMID>
  </reference>
  <reference>
    <citation>Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016 Nov 28;22(44):9694-9705. Review.</citation>
    <PMID>27956793</PMID>
  </reference>
  <reference>
    <citation>Lin QJ, Yang F, Jin C, Fu DL. Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015 Jul 14;21(26):7988-8003. doi: 10.3748/wjg.v21.i26.7988. Review.</citation>
    <PMID>26185370</PMID>
  </reference>
  <reference>
    <citation>Gleeson FC, Kipp BR, Caudill JL, Clain JE, Clayton AC, Halling KC, Henry MR, Rajan E, Topazian MD, Wang KK, Wiersema MJ, Zhang J, Levy MJ. False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors. Gut. 2010 May;59(5):586-93. doi: 10.1136/gut.2009.187765.</citation>
    <PMID>20427392</PMID>
  </reference>
  <reference>
    <citation>Erickson RA. EUS-guided FNA. Gastrointest Endosc. 2004 Aug;60(2):267-79. Review.</citation>
    <PMID>15278063</PMID>
  </reference>
  <reference>
    <citation>Chu LC, Goggins MG, Fishman EK. Diagnosis and Detection of Pancreatic Cancer. Cancer J. 2017 Nov/Dec;23(6):333-342. doi: 10.1097/PPO.0000000000000290. Review.</citation>
    <PMID>29189329</PMID>
  </reference>
  <reference>
    <citation>He M, Wu C, Xu J, Guo H, Yang H, Zhang X, Sun J, Yu D, Zhou L, Peng T, He Y, Gao Y, Yuan J, Deng Q, Dai X, Tan A, Feng Y, Zhang H, Min X, Yang X, Zhu J, Zhai K, Chang J, Qin X, Tan W, Hu Y, Lang M, Tao S, Li Y, Li Y, Feng J, Li D, Kim ST, Zhang S, Zhang H, Zheng SL, Gui L, Wang Y, Wei S, Wang F, Fang W, Liang Y, Zhai Y, Chen W, Miao X, Zhou G, Hu FB, Lin D, Mo Z, Wu T. A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk. Gut. 2014 Jan;63(1):143-51. doi: 10.1136/gutjnl-2012-303434. Epub 2013 Jan 7.</citation>
    <PMID>23300138</PMID>
  </reference>
  <reference>
    <citation>Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, Li J, Zhang K, Ye G, Ye L, Lv N, Zhang S, Liu C, Li M, Liu Q, Li R, Pan J, Yang X, Zhu X, Li Y, Lao B, Ling A, Chen H, Li X, Xu P, Zhou J, Liu B, Du Z, Du Y, Li Z; Gastrointestinal Early Cancer Prevention &amp; Treatment Alliance of China (GECA). Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019 Sep;68(9):1576-1587. doi: 10.1136/gutjnl-2018-317556. Epub 2019 Mar 29.</citation>
    <PMID>30926654</PMID>
  </reference>
  <reference>
    <citation>Nishiwada S, Sho M, Banwait JK, Yamamura K, Akahori T, Nakamura K, Baba H, Goel A. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases. Gastroenterology. 2020 Aug;159(2):562-574. doi: 10.1053/j.gastro.2020.04.057. Epub 2020 May 4.</citation>
    <PMID>32376411</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Xiangyu Kong</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

